NASDAQ: BLEUBleuacacia Ltd Stock
$10.82+0.13 (+1.22%)
Updated Apr 23, 2024
BLEU Price
$10.82
Fair Value Price
-$0.05
Market Cap
$81.75M
52 Week Low
$10.15
52 Week High
$11.40
P/E
51.52x
P/B
-7.22x
P/S
N/A
PEG
0.35x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$3.86M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$628k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
BLEU Overview
Bleuacacia Ltd is a "blank check" formed to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or related business combinations. It targets opportunities in the premium branded consumer retail sector. Bleuacacia Ltd was incorporated in 2021 and is based in New York, NY.
Zen Score
–
Industry Average (8)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BLEU scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BLEU ($10.82) is overvalued by 23,313.13% relative to our estimate of its Fair Value price of -$0.05 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BLEU ($10.82) is not significantly undervalued (23,313.13%) relative to our estimate of its Fair Value price of -$0.05 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BLEU ($10.82) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BLEU due diligence checks available for Premium users.
Be the first to know about important BLEU news, forecast changes, insider trades & much more!
BLEU News
Valuation
BLEU fair value
Fair Value of BLEU stock based on Discounted Cash Flow (DCF)
Price
$10.82
Fair Value
-$0.05
Undervalued by
23,313.13%
BLEU ($10.82) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BLEU ($10.82) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BLEU ($10.82) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BLEU price to earnings (PE)
For valuing profitable companies with steady earnings
Company
51.52x
Industry
35.99x
Market
41.27x
BLEU is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BLEU is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
BLEU price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-7.22x
Industry
-14.41x
BLEU price to earnings growth (PEG)
For valuing profitable companies with growth potential
BLEU is good value based... subscribe to Premium to read more.
PEG Value Valuation
BLEU's financial health
Profit margin
Revenue
$0.0
Net Income
-$371.5k
Profit Margin
0%
BLEU's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$17.1M
Liabilities
$11.5M
Debt to equity
-1.01
BLEU's short-term liabilities ($892.77k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BLEU's long-term liabilities ($10.56M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BLEU's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BLEU's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$104.6k
Investing
$0.0
Financing
$125.0k
BLEU's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BLEU vs Shell Company Stocks
Bleuacacia Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.